Transcriptional Profile of Cytokines, Regulatory Mediators and TLR in Mesenchymal Stromal Cells after Inflammatory Signaling and Cell-Passaging
- PMID: 34298927
- PMCID: PMC8306573
- DOI: 10.3390/ijms22147309
Transcriptional Profile of Cytokines, Regulatory Mediators and TLR in Mesenchymal Stromal Cells after Inflammatory Signaling and Cell-Passaging
Abstract
Adult human subcutaneous adipose tissue (AT) harbors a rich population of mesenchymal stromal cells (MSCs) that are of interest for tissue repair. For this purpose, it is of utmost importance to determine the response of AT-MSCs to proliferative and inflammatory signals within the damaged tissue. We have characterized the transcriptional profile of cytokines, regulatory mediators and Toll-like receptors (TLR) relevant to the response of MSCs. AT-MSCs constitutively present a distinct profile for each gene and differentially responded to inflammation and cell-passaging. Inflammation leads to an upregulation of IL-6, IL-8, IL-1β, TNFα and CCL5 cytokine expression. Inflammation and cell-passaging increased the expression of HGF, IDO1, PTGS1, PTGS2 and TGFβ. The expression of the TLR pattern was differentially modulated with TLR 1, 2, 3, 4, 9 and 10 being increased, whereas TLR 5 and 6 downregulated. Functional enrichment analysis demonstrated a complex interplay between cytokines, TLR and regulatory mediators central for tissue repair. This profiling highlights that following a combination of inflammatory and proliferative signals, the sensitivity and responsive capacity of AT-MSCs may be significantly modified. Understanding these transcriptional changes may help the development of novel therapeutic approaches.
Keywords: TLR; cell-passage; cytokines; inflammation; mesenchymal stromal cells; regulatory mediators; transcriptional profile.
Conflict of interest statement
The authors have no conflict of interest to declare. They confirm that there are no conflicts of interest associated with this publication. The manuscript has been read and approved by all named authors.
Figures









Similar articles
-
The Immunological Profile of Adipose Mesenchymal Stromal/Stem Cells after Cell Expansion and Inflammatory Priming.Biomolecules. 2024 Jul 15;14(7):852. doi: 10.3390/biom14070852. Biomolecules. 2024. PMID: 39062566 Free PMC article.
-
Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells.Hum Immunol. 2010 Mar;71(3):235-44. doi: 10.1016/j.humimm.2009.12.005. Epub 2010 Jan 6. Hum Immunol. 2010. PMID: 20034529
-
Empowering the immune fate of bone marrow mesenchymal stromal cells: gene and protein changes.Inflamm Res. 2019 Feb;68(2):167-176. doi: 10.1007/s00011-018-1198-8. Epub 2018 Nov 14. Inflamm Res. 2019. PMID: 30426152
-
Concise Review: TLR Pathway-miRNA Interplay in Mesenchymal Stromal Cells: Regulatory Roles and Therapeutic Directions.Stem Cells. 2018 Nov;36(11):1655-1662. doi: 10.1002/stem.2902. Epub 2018 Oct 13. Stem Cells. 2018. PMID: 30171669 Review.
-
Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential.Mediators Inflamm. 2010;2010:865601. doi: 10.1155/2010/865601. Epub 2010 Jun 14. Mediators Inflamm. 2010. PMID: 20628526 Free PMC article. Review.
Cited by
-
In Vitro Cellular and Molecular Interplay between Human Foreskin-Derived Mesenchymal Stromal/Stem Cells and the Th17 Cell Pathway.Pharmaceutics. 2021 Oct 19;13(10):1736. doi: 10.3390/pharmaceutics13101736. Pharmaceutics. 2021. PMID: 34684029 Free PMC article.
-
Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization.Front Cell Dev Biol. 2022 Jan 14;9:716853. doi: 10.3389/fcell.2021.716853. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35096805 Free PMC article. Review.
-
The Role of Pattern Recognition Receptors in Epigenetic and Metabolic Reprogramming: Insights into Trained Immunity.J Inflamm Res. 2025 Jun 13;18:7795-7811. doi: 10.2147/JIR.S513325. eCollection 2025. J Inflamm Res. 2025. PMID: 40535352 Free PMC article. Review.
-
Optimizing Mesenchymal Stem Cells for Regenerative Medicine: Influence of Diabetes, Obesity, Autoimmune, and Inflammatory Conditions on Therapeutic Efficacy: A Review.Med Sci Monit. 2024 Aug 18;30:e945331. doi: 10.12659/MSM.945331. Med Sci Monit. 2024. PMID: 39154207 Free PMC article. Review.
-
The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings.Front Cell Dev Biol. 2021 Aug 18;9:661532. doi: 10.3389/fcell.2021.661532. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34490235 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials